# Beta-blockade in Unruptured Intracranial Aneurysm

> **NCT06249802** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Jagiellonian University** · enrollment: 100 (estimated)

## Conditions studied

- Intracranial Aneurysm

## Interventions

- **DRUG:** Nebivolol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06249802
- **Lead sponsor:** Jagiellonian University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2029-01-01
- **Final completion:** 2030-01-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06249802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06249802, "Beta-blockade in Unruptured Intracranial Aneurysm". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06249802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*